Stocks and Investing Stocks and Investing
Fri, July 21, 2023

Mike Polark Upgraded (ABT) to Hold on, Jul 21st, 2023


Published on 2024-10-28 05:00:49 - WOPRAI, Mike Polark
  Print publication without navigation


Mike Polark of Wolfe Research, Upgraded "Abbott Laboratories" (ABT) to Hold on, Jul 21st, 2023.

Mike has made no other calls on ABT in the last 4 months.



There are 8 other peers that have a rating on ABT. Out of the 8 peers that are also analyzing ABT, 0 agree with Mike's Rating of Hold.



These are the ratings of the 8 analyists that currently disagree with Mike


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $123 on, Thursday, April 20th, 2023
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $130 on, Thursday, April 20th, 2023
  • Matt Miksic of "Barclays" Maintained at Buy with Increased Target to $127 on, Thursday, April 20th, 2023
  • Matthew Korn of "UBS" Maintained at Strong Buy with Increased Target to $130 on, Thursday, April 20th, 2023
  • Ryan Zimmerman of "BTIG" Maintained at Strong Buy with Increased Target to $130 on, Monday, April 17th, 2023
  • Lawrence Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $136 on, Monday, April 10th, 2023
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $136 on, Wednesday, April 5th, 2023
  • Danielle Antalffy of "UBS" Initiated at Strong Buy and Held Target at $117 on, Wednesday, March 29th, 2023

Contributing Sources